Literature DB >> 26607890

Complete Genome Sequences of Four African Horse Sickness Virus Strains from a Commercial Tetravalent Live Attenuated Vaccine.

Alan J Guthrie1, Peter Coetzee2, Darren P Martin3, Carina W Lourens4, Estelle H Venter2, Camilla T Weyer4, Christopher Joone4, Misha le Grange4, Cindy K Harper5, Peter G Howell4, N James MacLachlan6.   

Abstract

This is a report of the complete genome sequences of plaque-selected isolates of each of the four virus strains included in a South African commercial tetravalent African horse sickness attenuated live virus vaccine.
Copyright © 2015 Guthrie et al.

Entities:  

Year:  2015        PMID: 26607890      PMCID: PMC4661309          DOI: 10.1128/genomeA.01375-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

African horse sickness (AHS) is an arthropod-borne equine disease caused by African horse sickness virus (AHSV) (genus Orbivirus, family Reoviridae). The AHSV genome consists of 10 segments of double-stranded RNA (dsRNA) collectively encoding seven structural proteins and four nonstructural proteins (1). We report here the genome sequences of AHSV-2/Labstr/ZAF/1998/OBP-252.1 (serotype 2), AHSV-6/Labstr/ZAF/1998/OBP-252.1 (serotype 6), AHSV-7/Labstr/ZAF/1998/OBP-252.1 (serotype 7), and AHSV-8/Labstr/ZAF/1998/OBP-252.1 (serotype 8), which were isolated from bottle II of the South African polyvalent AHS attenuated live virus (ALV) vaccine (2) (Onderstepoort Biological Products [OBP] Ltd., Onderstepoort, South Africa). Individual serotypes were independently isolated using plaque selection on Vero cells in the presence of heterologous antibody to the other serotypes contained in the tetravalent vaccine, as previously described (3). Each of these viruses was then passaged on monolayers of baby hamster kidney (BHK-21) cells, and AHSV dsRNA was extracted, cDNA was prepared (4), and amplicons were sequenced on an Illumina MiSeq sequencer using the Nextera XT DNA sample preparation kit and 300-bp paired-end V3 Illumina chemistry, as previously described (5). Sequence reads were analyzed using de novo assembly, followed by mapping in Geneious 8.1.7 to obtain full-length genome sequences of the four viruses. The genome sequences of AHSV serotype 2 (HS82/61) and serotype 6 (HS02/75) viruses, which are precursors of the respective AHS-ALV virus strains, are available from GenBank (KF859996 to KF860005 and KP009741 to KP009750, respectively). The pairwise nucleotide sequence identity of AHSV-2/Labstr/ZAF/1998/OBP-252.1 and HS82/61 was 99.536%, while that of AHSV-6/Labstr/ZAF/1998/OBP-252.1 and HS02/75 was 99.350%. The genome sequences of the AHSV serotype 7 strain with a truncated VP2 protein (AHSV7-tVP2) (6) from which AHSV-7/Labstr/ZAF/1998/OBP-252.1 was derived are available from GenBank (accession numbers JQ742006 to JQ742015). The pairwise nucleotide sequence identity between AHSV-7/Labstr/ZAF/1998/OBP-252.1 and AHSV7-tVP2 was >99.3% for all segments, except those encoding the VP5 and nonstructural 2 (NS2) proteins, which were lower, at 77.4% and 97.9%, respectively. Analysis using RDP4.56 (7), as described previously (5), showed that AHSV-7/Labstr/ZAF/1998/OBP-252.1 is a reassortant (P = 7.56 × 10-156) composed of eight segments likely derived from AHSV7-tVP2 (accession numbers JQ742006 to JQ742010, JQ742012, JQ742013, and JQ742015), and the other segments likely derived from HS39/63 (accession numbers KF860011 and KF860013). The genome sequences of the AHSV serotype 8 (HS10/62) from which AHSV-8/Labstr/ZAF/1998/OBP-252.1 was derived are available from GenBank (accession numbers KF860026 to KF860035). Pairwise nucleotide sequence identity between AHSV-8/Labstr/ZAF/1998/OBP-252.1 and HS10/62 over four of the 10 segments was >99.9%, while that for the remaining segments was between 76.8% and 97.4%. Analysis using RDP4.56 (7) showed that AHSV-8/Labstr/ZAF/1998/OBP-252.1 is a reassortant composed of four genome segments (accession numbers KF860026 to KF860028 and KF860034) likely derived from HS10/62, segments encoding NS1, VP5, VP7, and VP6 (accession numbers KM886348 to KM886350 and KM886352) likely derived from HS30/62 (P = 2.71 × 10-282), and the segments encoding VP4 and NS3 likely derived from an AHSV for which whole-genome sequence data are currently not available (P = 3.72 × 10-126 and 4.05 × 10-59, respectively).

Nucleotide sequence accession numbers.

The AHSV-2/Labstr/ZAF/1998/OBP-252.1, AHSV-6/Labstr/ZAF/1998/OBP-252.1, AHSV-7/Labstr/ZAF/1998/OBP-252.1, and AHSV-8/Labstr/ZAF/1998/OBP-252.1 sequences have been deposited in GenBank under accession numbers KT715601 to KT715610, KT715611 to KT715620, KT715621 to KT715630, and KT715631 to KT715640, respectively.
  6 in total

1.  Structural insight into African horsesickness virus infection.

Authors:  Violeta Manole; Pasi Laurinmäki; Wouter Van Wyngaardt; Christiaan A Potgieter; Isabella M Wright; Gert J Venter; Alberdina A van Dijk; B Trevor Sewell; Sarah J Butcher
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  The application of improved techniques to the identification of strains of bluetongue virus.

Authors:  P G Howell; N A Kümm; M J Botha
Journal:  Onderstepoort J Vet Res       Date:  1970-03       Impact factor: 1.792

3.  In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6.

Authors:  Beate F von Teichman; Baptiste Dungu; Theresa K Smit
Journal:  Vaccine       Date:  2010-07-16       Impact factor: 3.641

4.  Improved strategies for sequence-independent amplification and sequencing of viral double-stranded RNA genomes.

Authors:  A C Potgieter; N A Page; J Liebenberg; I M Wright; O Landt; A A van Dijk
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

5.  Complete Genome Sequences of the Three African Horse Sickness Virus Strains from a Commercial Trivalent Live Attenuated Vaccine.

Authors:  Alan J Guthrie; Peter Coetzee; Darren P Martin; Carina W Lourens; Estelle H Venter; Camilla T Weyer; Christopher Joone; Misha le Grange; Cindy K Harper; Peter G Howell; N James MacLachlan
Journal:  Genome Announc       Date:  2015-08-20

6.  Characterising Non-Structural Protein NS4 of African Horse Sickness Virus.

Authors:  Lizahn Zwart; Christiaan A Potgieter; Sarah J Clift; Vida van Staden
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  6 in total
  3 in total

1.  A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture.

Authors:  Mathilde L Schade-Weskott; Antoinette van Schalkwyk; J J O Koekemoer
Journal:  Virus Genes       Date:  2018-05-05       Impact factor: 2.332

2.  Evidence of Intragenic Recombination in African Horse Sickness Virus.

Authors:  Harry G Ngoveni; Antoinette van Schalkwyk; J J Otto Koekemoer
Journal:  Viruses       Date:  2019-07-18       Impact factor: 5.048

3.  African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.

Authors:  Camilla T Weyer; John D Grewar; Phillippa Burger; Esthea Rossouw; Carina Lourens; Christopher Joone; Misha le Grange; Peter Coetzee; Estelle Venter; Darren P Martin; N James MacLachlan; Alan J Guthrie
Journal:  Emerg Infect Dis       Date:  2016-12-15       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.